Fatty acid non-flushing niacin derivatives and their uses
AssigneeCatabasis Pharmaceuticals, Inc.
InventorsChi B. Vu, Jean E. Bemis, Michael R. Jirousek, Jill C. Milne, Amal Ting
Life of this patent
Estimating the term…
Abstract
The invention relates to fatty non-flushing acid niacin derivatives; compositions comprising an effective amount of a fatty acid non-flushing niacin derivative; and methods for treating or preventing an metabolic disease comprising the administration of an effective amount of a fatty acid non-flushing niacin derivative.
Claims12
A molecular conjugate comprising a non-flushing niacin and a fatty acid selected from lipoic acid, omega-3 fatty acids or fatty acids metabolized in vivo into omega-3 fatty acids.
A compound of Formula I:
- or a pharmaceutically acceptable salt, enantiomer or stereoisomer thereof;
- wherein
- Each R1 and R2 is independently hydrogen, deuterium, —C1-C4 alkyl, -halogen, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, —C1-C3 alkene, —C1-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, or —S(O)2C1-C3 alkyl;
- R5 is independently selected from the group consisting of H, -D, —Cl, —F, —CN, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —C(O)H, —C(O)C1-C3 alkyl, —C(O)OC1-C3 alkyl, —C(O)NH2, —C(O)NH(C1-C3 alkyl), —C(O)N(C1-C3 alkyl)2, —C1-C6 alkyl, —O—C1-C3 alkyl, —S(O)C1-C3 alkyl, —S(O)2C1-C3 alkyl, an aryl, a cycloalkyl, a heterocycle and
- R3 is independently H or C1-C6 alkyl, or both R3 groups, when taken together with the nitrogen to which they are attached, can form
- wherein f1 is 1, 2, 3 or 4;
- and f2 is 1, 2 or 3;
- W1 and W2 are each independently null, O, S, NH, NR, or W1 and W2 can be taken together can form an imidazolidine or piperazine group, with the proviso that W1 and W2 can not be O simultaneously;
- each a, b, c, and d is independently —H, -D, —CH3, —OCH3, —OCH2CH3, —C(O)OR, —O—Z, or benzyl, or two of a, b, c, and d can be taken together, along with the single carbon to which they are bound, to form a cycloalkyl or heterocycle;
- each n, o, p, and q is independently 0, 1 or 2;
- each L is independently —O—, —S—, —S(O)—, —S(O)2—, —S—S—, —(C1-C6alkyl)-, —(C3-C6cycloalkyl)-, a heterocycle, a heteroaryl,
- wherein the representation of L is not limited directionally left to right as is depicted, rather either the left side or the right side of L can be bound to the W1 side of the compound of Formula I;
- R6 is independently —H, -D, —C1-C4 alkyl, -halogen, cyano, oxo, thiooxo, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, —C1-C3 alkene, —C1-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, or —S(O)2C1-C3 alkyl;
- each g is independently 2, 3 or 4;
- each h is independently 1, 2, 3 or 4;
- m is 0, 1, 2, 3, 4 or 5;
- if m is more than 1, then L can be the same or different;
- m1 is 0, 1, 2 or 3;
- k is 0, 1, 2, or 3;
- z is 1, 2, or 3;
- each R4 independently e, H or straight or branched C1-C10 alkyl which can be optionally substituted with OH, NH2, CO2R, CONH2, phenyl, C6H4OH, imidazole or arginine;
- each e is independently H or any one of the side chains of the naturally occurring amino acids;
- each Z is independently —H, or
- with the proviso that there is at least one
- in the compound;
- each r is independently 2, 3, or 7;
- each s is independently 3, 5, or 6;
- each t is independently 0 or 1;
- each v is independently 1, 2, or 6;
- each R is independently —H, —C1-C3 alkyl, or straight or branched C1-C4 alkyl optionally substituted with OH, or halogen;
- provided that
- when m, n, o, p, and q are each 0, W1 and W2 are each null, and Z is
- then t must be 0;
- and
- when m, n, o, p, and q are each 0, and W1 and W2 are each null, then Z must not be
A compound of the Formula II:
- or a pharmaceutically acceptable salt, enantiomer or stereoisomer thereof;
- wherein
- each R1 and R2 is independently hydrogen, deuterium, —C1-C4 alkyl, -halogen, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, —C1-C3 alkene, —C1-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, —S(O)2C1-C3 alkyl;
- R3 is independently H or C1-C6 alkyl, or both R3 groups, when taken together with the nitrogen to which they are attached, can form
- wherein f1 is 1, 2, 3 or 4;
- W1 and W2 are each independently null, O, S, NH, NR, or W1 and W2 can be taken together can form an imidazolidine or piperazine group, with the proviso that W1 and W2 can not be O simultaneously;
- each a, b, c, and d is independently —H, -D, —CH3, —OCH3, —OCH2CH3, —C(O)OR, —O—Z, or benzyl, or two of a, b, c, and d can be taken together, along with the single carbon to which they are bound, to form a cycloalkyl or heterocycle;
- each n, o, p, and q is independently 0, 1 or 2;
- each L is independently-O—, —S—, —S(O)—, —S(O)2—, —S—S—, —(C1-C6alkyl)-, —(C3-C6cycloalkyl)-, a heterocycle, a heteroaryl,
- wherein the representation of L is not limited directionally left to right as is depicted, rather either the left side or the right side of L can be bound to the W1 side of the compound of Formula II;
- R6 is independently —H, -D, —C1-C4 alkyl, -halogen, cyano, oxo, thiooxo, —OH, —C(O)C1-C4 alkyl, —O-aryl, —O-benzyl, —OC(O)C1-C4 alkyl, —C1-C3 alkene, —C1-C3 alkyne, —C(O)C1-C4 alkyl, —NH2, —NH(C1-C3 alkyl), —N(C1-C3 alkyl)2, —NH(C(O)C1-C3 alkyl), —N(C(O)C1-C3 alkyl)2, —SH, —S(C1-C3 alkyl), —S(O)C1-C3 alkyl, or —S(O)2C1-C3 alkyl;
- each g is independently 2, 3 or 4;
- each h is independently 1, 2, 3 or 4;
- m is 0, 1, 2, 3, 4 or 5;
- if m is more than 1, then L can be the same or different;
- m1 is 0, 1, 2 or 3;
- k is 0, 1, 2, or 3;
- z is 1, 2, or 3;
- each R4 independently e, H or straight or branched C1-C10 alkyl which can be optionally substituted with OH, NH2, CO2R, CONH2, phenyl, C6H4OH, imidazole or arginine;
- each e is independently H or any one of the side chains of the naturally occurring amino acids;
- each Z is independently —H, or
- with the proviso that there is at least one
- in the compound;
- each r is independently 2, 3, or 7;
- each s is independently 3, 5, or 6;
- each t is independently 0 or 1;
- each v is independently 1, 2, or 6;
- each R is independently —H, —C1-C3 alkyl, or straight or branched C1-C4 alkyl optionally substituted with OH, or halogen;
- provided that
- when m, n, o, p, and q are each 0, W1 and W2 are each null, and Z is
- then t must be 0;
- and
- when m, n, o, p, and q are each 0, and W1 and W2 are each null, then Z must not be
Dependencies are inferred from the claim text.